Tags

Type your tag names separated by a space and hit enter

Continuous glucose monitoring in type 2 diabetes.
Diabetes Res Clin Pract. 2008 Dec 15; 82 Suppl 2:S118-21.DR

Abstract

The utility and efficacy of self-monitoring of blood glucose (SMBG), using single capillary glucose determinations, in the management of non-insulin treated type 2 diabetes has been called into question. The use of continuous sub-cutaneous glucose monitoring (CGM) systems provides an answer for at least some of the inadequacies attributed to point capillary SMBG. The use of CGM adds information on postprandial glucose excursions, nocturnal hypoglycemia or hyperglycemia not previously detected by SMBG. This added information facilitates the tailoring of treatment regimens to the individual patient in order to achieve treatment targets without incurring an increased risk of hypoglycemia and provides a useful tool for patient self-management education.

Authors+Show Affiliations

Department of Internal Medicine C and Diabetes Unit, Soroka University Medical Center, Beer-Sheva 84101, Israel. ilanahb@bgu.ac.il

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

19027978

Citation

Harman-Boehm, Ilana. "Continuous Glucose Monitoring in Type 2 Diabetes." Diabetes Research and Clinical Practice, vol. 82 Suppl 2, 2008, pp. S118-21.
Harman-Boehm I. Continuous glucose monitoring in type 2 diabetes. Diabetes Res Clin Pract. 2008;82 Suppl 2:S118-21.
Harman-Boehm, I. (2008). Continuous glucose monitoring in type 2 diabetes. Diabetes Research and Clinical Practice, 82 Suppl 2, S118-21. https://doi.org/10.1016/j.diabres.2008.09.051
Harman-Boehm I. Continuous Glucose Monitoring in Type 2 Diabetes. Diabetes Res Clin Pract. 2008 Dec 15;82 Suppl 2:S118-21. PubMed PMID: 19027978.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Continuous glucose monitoring in type 2 diabetes. A1 - Harman-Boehm,Ilana, Y1 - 2008/11/22/ PY - 2008/11/26/pubmed PY - 2009/4/21/medline PY - 2008/11/26/entrez SP - S118 EP - 21 JF - Diabetes research and clinical practice JO - Diabetes Res Clin Pract VL - 82 Suppl 2 N2 - The utility and efficacy of self-monitoring of blood glucose (SMBG), using single capillary glucose determinations, in the management of non-insulin treated type 2 diabetes has been called into question. The use of continuous sub-cutaneous glucose monitoring (CGM) systems provides an answer for at least some of the inadequacies attributed to point capillary SMBG. The use of CGM adds information on postprandial glucose excursions, nocturnal hypoglycemia or hyperglycemia not previously detected by SMBG. This added information facilitates the tailoring of treatment regimens to the individual patient in order to achieve treatment targets without incurring an increased risk of hypoglycemia and provides a useful tool for patient self-management education. SN - 1872-8227 UR - https://www.unboundmedicine.com/medline/citation/19027978/Continuous_glucose_monitoring_in_type_2_diabetes_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0168-8227(08)00465-8 DB - PRIME DP - Unbound Medicine ER -